{
    "2021-08-27": [
        [
            {
                "time": "",
                "original_text": "安信证券维持益丰药房买入评级：业绩增长具备持续性，2021H1业绩增长符合预期",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "买入评级",
                        "业绩增长",
                        "持续性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国盛证券维持益丰药房买入评级：业绩基本符合预期，下半年有望持续改善",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "买入评级",
                        "业绩",
                        "下半年",
                        "改善"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "益丰药房2021年中报点评：内生外延双轮驱动，门店网络稳步扩张！【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "中报",
                        "内生外延",
                        "门店扩张"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "214家药店，益丰药房收了",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "药店收购",
                        "扩张"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "用户过亿 京东健康推动医疗数智化再下一城",
                "features": {
                    "keywords": [
                        "京东健康",
                        "医疗数智化",
                        "用户过亿"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "益丰药房发半年报股价跌5.6% 营收73亿销售费用19亿 盈利能力下降",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "半年报",
                        "股价下跌",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "45公司获得推荐评级-更新中",
                "features": {
                    "keywords": [
                        "推荐评级",
                        "更新中"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国金证券：维持益丰药房(603939.SH)“买入”评级 毛利率上升 期待下半年业绩高速增长",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "买入评级",
                        "毛利率上升",
                        "下半年",
                        "高速增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【发底层】半年报解读|益丰药房：聚焦区域扩门店 净利增25% Q3起行业增速回升可期",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "半年报",
                        "净利增长",
                        "Q3",
                        "行业增速回升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "益丰2021年中报：营收73.46亿元，门店大增897家！",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "中报",
                        "营收",
                        "门店增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}